Platelet activating factor

Platelet activating factor is a lipid of Glycerophospholipids (GP) class. Platelet activating factor is associated with abnormalities such as Atherosclerosis, Acute cholecystitis without calculus, Cholecystitis, Colitis and Cholecystitis, Acute. The involved functions are known as Cell Survival, Metabolic Inhibition, lipid oxidation, Apoptosis and Oxidation. Platelet activating factor often locates in soluble, Cellular Membrane, Smooth muscle (tissue), Intima and Tissue specimen. The associated genes with Platelet activating factor are apolipoprotein A-I Milano, Homologous Gene, TSPO gene, HBEGF gene and SLC33A1 gene. The related lipids are Hydroxycholesterols, Liposomes, 25-hydroxycholesterol, Lysophosphatidylcholines and Lipopolysaccharides. The related experimental models are Knock-out, Mouse Model and Transgenic Model.

Cross Reference

Introduction

To understand associated biological information of Platelet activating factor, we collected biological information of abnormalities, associated pathways, cellular/molecular locations, biological functions, related genes/proteins, lipids and common seen animal/experimental models with organized paragraphs from literatures.

What diseases are associated with Platelet activating factor?

Platelet activating factor is suspected in Ischemia, Pleurisy, Atherosclerosis, Inflammatory disorder, Retinal Diseases, Diabetes and other diseases in descending order of the highest number of associated sentences.

Related references are mostly published in these journals:

Disease Cross reference Weighted score Related literature
Loading... please refresh the page if content is not showing up.

Possible diseases from mapped MeSH terms on references

We collected disease MeSH terms mapped to the references associated with Platelet activating factor

MeSH term MeSH ID Detail
Asphyxia Neonatorum D001238 4 associated lipids
Melanoma D008545 69 associated lipids
Asthma D001249 52 associated lipids
Weight Gain D015430 101 associated lipids
Brain Diseases D001927 27 associated lipids
Cardiovascular Diseases D002318 24 associated lipids
Hypersensitivity, Delayed D006968 43 associated lipids
Glioma D005910 112 associated lipids
Staphylococcal Infections D013203 15 associated lipids
Cell Transformation, Neoplastic D002471 126 associated lipids
Per page 10 20 50 100 | Total 288

PubChem Associated disorders and diseases

What pathways are associated with Platelet activating factor

There are no associated biomedical information in the current reference collection.

PubChem Biomolecular Interactions and Pathways

Link to PubChem Biomolecular Interactions and Pathways

What cellular locations are associated with Platelet activating factor?

Related references are published most in these journals:

Location Cross reference Weighted score Related literatures
Loading... please refresh the page if content is not showing up.

What functions are associated with Platelet activating factor?


Related references are published most in these journals:

Function Cross reference Weighted score Related literatures

What lipids are associated with Platelet activating factor?

Related references are published most in these journals:

Lipid concept Cross reference Weighted score Related literatures
Loading... please refresh the page if content is not showing up.

What genes are associated with Platelet activating factor?

Related references are published most in these journals:


Gene Cross reference Weighted score Related literatures

What common seen animal models are associated with Platelet activating factor?

Knock-out

Knock-out are used in the study 'A cardioprotective role for platelet-activating factor through NOS-dependent S-nitrosylation.' (Leary PJ et al., 2008).

Mouse Model

Mouse Model are used in the study 'A regulatory role of LPCAT1 in the synthesis of inflammatory lipids, PAF and LPC, in the retina of diabetic mice.' (Cheng L et al., 2009).

Transgenic Model

Transgenic Model are used in the study 'Heterogeneity in the sn-1 carbon chain of platelet-activating factor glycerophospholipids determines pro- or anti-apoptotic signaling in primary neurons.' (Ryan SD et al., 2008).

Related references are published most in these journals:

Model Cross reference Weighted score Related literatures
Loading... please refresh the page if content is not showing up.

NCBI Entrez Crosslinks

All references with Platelet activating factor

Download all related citations
Per page 10 20 50 100 | Total 8526
Authors Title Published Journal PubMed Link
Pávó I et al. Interactions of pro-inflammatory and vasoactive mediators with nitric oxide in the regulation of rat vascular permeability during laparotomy. 2000 Eur. J. Pharmacol. pmid:10940373
Baskova I et al. Inhibition of induced and spontaneous platelet aggregation by destabilase from medicinal leech. 2000 Platelets pmid:10938885
Raible DG et al. Hydrogen peroxide release from human eosinophils on fibronectin: scopoletin enhances eosinophil activation. 2000 Free Radic. Biol. Med. pmid:10938462
Miyatake T et al. Analysis of cardiac function during hyperacute rejection: effects of PAF antagonist, TXA(2) inhibitor/antagonists, and nitroglycerin. 2000 Transplant. Proc. pmid:10936319
Haribabu B et al. Targeted disruption of the leukotriene B(4) receptor in mice reveals its role in inflammation and platelet-activating factor-induced anaphylaxis. 2000 J. Exp. Med. pmid:10934231
Henig NR et al. Effect of recombinant human platelet-activating factor-acetylhydrolase on allergen-induced asthmatic responses. 2000 Am. J. Respir. Crit. Care Med. pmid:10934081
Capasso R et al. Preventive effect of eugenol on PAF and ethanol-induced gastric mucosal damage. 2000 Fitoterapia pmid:10930724
Matsunaga Y et al. Regulation of lymphocyte proliferation by eosinophils via chymotrypsin-like protease activity and adhesion molecule interaction. 2000 Br. J. Pharmacol. pmid:10928955
Roudebush WE and Purnell ET Platelet-activating factor content in human spermatozoa and pregnancy outcome. 2000 Fertil. Steril. pmid:10927041
Klyubin IV et al. The role of reactive oxygen species in membrane potential changes in macrophages and astrocytes. 2000 Membr Cell Biol pmid:10926373
O'Brien JG et al. Effects of tranexamic acid and aprotinin, two antifibrinolytic drugs, on PAF-induced plasma extravasation in unanesthetized rats. 2000 Inflammation pmid:10921506
Smalley DM et al. The local effect of PAF on leukocyte adherence to small bowel mesenteric venules following intra-abdominal contamination. 2000 Inflammation pmid:10921505
Choi JH et al. Selective involvement of reactive oxygen intermediates in platelet-activating factor-mediated activation of NF-kappaB. 2000 Inflammation pmid:10921504
Hu GL and Guo HS [Progress in platelet-activating factor receptor research]. 1997 Sheng Li Ke Xue Jin Zhan pmid:10921090
Unno N et al. Plasma platelet-activating factor acetylhydrolase deficiency is associated with atherosclerotic occlusive disease in japan. 2000 J. Vasc. Surg. pmid:10917985
Parrish PR and Larson DF Pharmacological effect of nitroprusside on platelet aggregation. 1999 J Extra Corpor Technol pmid:10915472
Francescangeli E et al. Properties and regulation of microsomal PAF-synthesizing enzymes in rat brain cortex. 2000 Neurochem. Res. pmid:10905633
Baker RR Lipid acetylation reactions and the metabolism of platelet-activating factor. 2000 Neurochem. Res. pmid:10905630
Wang JH and Sun GY Platelet activating factor (PAF) antagonists on cytokine induction of iNOS and sPLA2 in immortalized astrocytes (DITNC). 2000 Neurochem. Res. pmid:10905622
Clark GD et al. Neuronal platelet-activating factor receptor signal transduction involves a pertussis toxin-sensitive G-protein. 2000 Neurochem. Res. pmid:10905621
Parkman HP et al. The contractile action of platelet-activating factor on gallbladder smooth muscle. 2000 Am. J. Physiol. Gastrointest. Liver Physiol. pmid:10898747
Hu L et al. Alkyl and alkoxycarbonyl derivatives of ginkgolide B: synthesis and biological evaluation of PAF inhibitory activity. 2000 Bioorg. Med. Chem. pmid:10896127
Rose F et al. E. coli hemolysin-induced lipid mediator metabolism in alveolar macrophages: impact of eicosapentaenoic acid. 2000 Am. J. Physiol. Lung Cell Mol. Physiol. pmid:10893208
Lee YM et al. Platelet-activating factor contributes to acute lung leak in rats given interleukin-1 intratracheally. 2000 Am. J. Physiol. Lung Cell Mol. Physiol. pmid:10893205
Bailey SR et al. Differential activation of platelets from normal and allergic ponies by PAF and ADP. 2000 Inflamm. Res. pmid:10893045
Folch E et al. H(2)O(2) and PARS mediate lung P-selectin upregulation in acute pancreatitis. 2000 Free Radic. Biol. Med. pmid:10889459
Dent G et al. Involvement of protein tyrosine kinases in activation of human eosinophils by platelet-activating factor. 2000 Immunology pmid:10886400
Aihara M et al. Interaction between neurone and microglia mediated by platelet-activating factor. 2000 Genes Cells pmid:10886367
Tektonidou MG et al. Clinical importance of antibodies against platelet activating factor in antiphospholipid syndrome manifestations. 2000 Eur. J. Clin. Invest. pmid:10886305
Kusuhara H et al. Y-24180, an antagonist of platelet-activating factor, suppresses interleukin 5 production in cultured murine th(2)cells and human peripheral blood mononuclear cells. 2000 Cytokine pmid:10880261
Viswanath M et al. Reduction of hypoxic-ischemic brain swelling in the neonatal rat with PAF antagonist WEB 2170: lack of long-term protection. 2000 Pediatr. Res. pmid:10879808
Xu H et al. Platelet-activating factor acetylhydrolase gene mutation in Japanese children with Escherichia coli O157-associated hemolytic uremic syndrome. 2000 Am. J. Kidney Dis. pmid:10873870
Suzuki S et al. The roles of platelet-activating factor and endothelin-1 in renal damage after total hepatic ischemia and reperfusion. 2000 Transplantation pmid:10868624
Alappatt C et al. Acute keratinocyte damage stimulates platelet-activating factor production. 2000 Arch. Dermatol. Res. pmid:10867814
Bae K et al. Platelet-activating factor (PAF)-dependent transacetylase and its relationship with PAF acetylhydrolases. 2000 J. Biol. Chem. pmid:10867005
Cavallo-Perin P et al. Increased blood levels of platelet-activating factor in insulin-dependent diabetic patients with microalbuminuria. 2000 Nephrol. Dial. Transplant. pmid:10862637
Huo LJ and Yang ZM Effects of platelet activating factor on capacitation and acrosome reaction in mouse spermatozoa. 2000 Mol. Reprod. Dev. pmid:10862011
Denizot Y et al. Effect of cytokines and lipid mediators on the synthesis of interleukin 1 beta by human bone marrow stromal cells. 2000 Cytokine pmid:10857767
Nakajima T et al. Phospholipase A2-mediated superoxide production of murine peritoneal macrophages induced by chrysotile stimulation. 2000 Int. J. Biochem. Cell Biol. pmid:10856708
Caslake MJ et al. Lipoprotein-associated phospholipase A(2), platelet-activating factor acetylhydrolase: a potential new risk factor for coronary artery disease. 2000 Atherosclerosis pmid:10856534
Zhu X et al. A surrogate method for assessment of beta(2)-integrin-dependent adhesion of human eosinophils to ICAM-1. 2000 J. Immunol. Methods pmid:10854610
Fukuyama S et al. Effect of eotaxin and platelet-activating factor on airway inflammation and hyperresponsiveness in guinea pigs in vivo. 2000 Am. J. Respir. Crit. Care Med. pmid:10852755
Poveshchenko AF and Kozlov VA [The effect of platelet-activating factor and its antagonist--BN 52021--on immune reactions in vivo in mice and in vitro]. 1999 Jul-Aug Zh. Mikrobiol. Epidemiol. Immunobiol. pmid:10852052
Kobayashi N et al. Transepithelial migration of activated eosinophils induces a decrease of E-cadherin expression in cultured human nasal epithelial cells. 2000 Clin. Exp. Allergy pmid:10848899
Ma X and Bazan HE Increased platelet-activating factor receptor gene expression by corneal epithelial wound healing. 2000 Invest. Ophthalmol. Vis. Sci. pmid:10845588
Serradji N et al. Structure-activity relationships in platelet-activating factor (PAF). 10. From PAF antagonism to inhibition of HIV-1 replication. 2000 J. Med. Chem. pmid:10841793
Mizutani Y et al. Cloning and expression of rat neutral sphingomyelinase: enzymological characterization and identification of essential histidine residues. 2000 Biochim. Biophys. Acta pmid:10832103
Tokumura A et al. Structural identification of phosphatidylcholines having an oxidatively shortened linoleate residue generated through its oxygenation with soybean or rabbit reticulocyte lipoxygenase. 2000 J. Lipid Res. pmid:10828088
Asai Y et al. Characterization of the physicochemical properties of the micelles of platelet-activating factor (C18:0). 2000 Drug Dev Ind Pharm pmid:10826115
Ohishi S [Evaluation of time course and inter-relationship of inflammatory mediators in experimental inflammatory reaction]. 2000 Yakugaku Zasshi pmid:10825809